HRP20201598T1 - Pripravci - Google Patents
Pripravci Download PDFInfo
- Publication number
- HRP20201598T1 HRP20201598T1 HRP20201598TT HRP20201598T HRP20201598T1 HR P20201598 T1 HRP20201598 T1 HR P20201598T1 HR P20201598T T HRP20201598T T HR P20201598TT HR P20201598 T HRP20201598 T HR P20201598T HR P20201598 T1 HRP20201598 T1 HR P20201598T1
- Authority
- HR
- Croatia
- Prior art keywords
- aqueous solution
- cassette
- solution
- cassette according
- mosm
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000007864 aqueous solution Substances 0.000 claims 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- IQWHCHZFYPIVRV-UHFFFAOYSA-I pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatome Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].CCC(C)CCCCC(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC(C(C)O)C(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS([O-])(=O)=O)NC1=O IQWHCHZFYPIVRV-UHFFFAOYSA-I 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 108010040201 Polymyxins Proteins 0.000 claims 1
- 239000003708 ampul Substances 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (11)
1. Vodena otopina koja sadrži od 80 mg A/mL do 400 mg A/mL sulfometiliranog polimiksina.
2. Otopina prema zahtjevu 1, koja sadrži od 80 mg A/mL do 300 mg A/mL natrij-kolistimetata.
3. Otopina prema zahtjevu 2, koja sadrži od 85 mg A/mL do 150 mg A/mL natrij-kolistimetata.
4. Otopina prema zahtjevu 3, koja sadrži od 90 mg A/mL do 120 mg A/mL natrij-kolistimetata.
5. Kazeta koja sadrži otopinu prema bilo kojem od zahtjeva 1-4.
6. Kazeta prema zahtjevu 5, naznačena time da je to staklena ampula, injekcija spremna za uporabu, ili „blow-fill“ zapečaćena posuda.
7. Kazeta prema zahtjevu 5, naznačena time da vodena otopina sadrži od 0% tež./zapr. NaCl do 0.9% tež./zapr. NaCl.
8. Kazeta prema zahtjevu 5, naznačena time da vodena otopina ima osmolalnost od 500 mOsm/kg do 1300 mOsm/kg.
9. Kazeta prema zahtjevu 5, naznačena time da vodena otopina ima pH vrijednost od 6 do 9.
10. Kazeta prema zahtjevu 5, naznačena time da vodena otopina ima pH vrijednost od 6 do 7.
11. Vodena otopina prema bilo kojem od zahtjeva 1-4, za primjenu u terapijskom ili profilaktičkom tretmanu bakterijske infekcije plućnog sistema.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462059711P | 2014-10-03 | 2014-10-03 | |
| PCT/EP2015/072728 WO2016050928A1 (en) | 2014-10-03 | 2015-10-01 | Compositions |
| EP15775173.6A EP3200827B1 (en) | 2014-10-03 | 2015-10-01 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20201598T1 true HRP20201598T1 (hr) | 2021-02-19 |
Family
ID=54252294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20201598TT HRP20201598T1 (hr) | 2014-10-03 | 2020-10-07 | Pripravci |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US10532080B2 (hr) |
| EP (2) | EP3200827B1 (hr) |
| JP (1) | JP6633061B2 (hr) |
| KR (1) | KR102433278B1 (hr) |
| CN (1) | CN106794221B (hr) |
| AU (1) | AU2015326842B2 (hr) |
| BR (1) | BR112017006848B1 (hr) |
| CA (1) | CA2961700C (hr) |
| CO (1) | CO2017004303A2 (hr) |
| DK (1) | DK3200827T3 (hr) |
| ES (1) | ES2822943T3 (hr) |
| HR (1) | HRP20201598T1 (hr) |
| HU (1) | HUE052028T2 (hr) |
| IL (1) | IL251479B (hr) |
| MX (1) | MX2017004176A (hr) |
| PH (1) | PH12017500516A1 (hr) |
| PL (1) | PL3200827T3 (hr) |
| PT (1) | PT3200827T (hr) |
| RS (1) | RS60874B1 (hr) |
| RU (1) | RU2712276C2 (hr) |
| SG (1) | SG11201702717XA (hr) |
| SI (1) | SI3200827T1 (hr) |
| UA (1) | UA119573C2 (hr) |
| WO (1) | WO2016050928A1 (hr) |
| ZA (1) | ZA201702047B (hr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2895910C (en) | 2013-01-11 | 2021-12-21 | Xellia Pharmaceuticals Aps | Polymyxins, compositions, methods of making and methods of use |
| ES2749053T3 (es) | 2014-07-09 | 2020-03-18 | Xellia Pharmaceuticals Aps | Polimixinas de baja sustitución y sus composiciones |
| CA2962120C (en) | 2014-10-03 | 2023-09-19 | Xellia Pharmaceuticals Aps | Inhalation device |
| CN112546030A (zh) * | 2019-09-26 | 2021-03-26 | 盈科瑞（天津）创新医药研究有限公司 | 一种吸入用多粘菌素e甲磺酸钠溶液及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1062895A (en) | 1962-12-13 | 1967-03-22 | Wellcome Found | Sulphomethyl derivatives of polymxin |
| DE1906699A1 (de) | 1968-02-12 | 1970-02-05 | Pfizer | Neue Polymyxinderivate und Verfahren zu deren Herstellung |
| FR1586834A (hr) | 1968-02-12 | 1970-03-06 | ||
| WO1989009626A1 (en) | 1988-04-07 | 1989-10-19 | Luther Ronald B | Non-thrombogenic intravascular time release catheter |
| AU639952B2 (en) * | 1989-11-15 | 1993-08-12 | Novartis Ag | Polymyxin conjugates |
| JP3345652B2 (ja) * | 1994-06-29 | 2002-11-18 | 明治製菓株式会社 | 硫酸コリスチンを含有してなる安定化された組成物 |
| JP2001505557A (ja) * | 1996-11-15 | 2001-04-24 | パソジェネシス コーポレイション | 肺感染を処置するための、純粋な生物学的活性コリスチン、その成分、およびコリスチン処方物 |
| US5767068A (en) | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| EP2186508A3 (en) | 2001-05-18 | 2010-08-25 | Novartis AG | Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| US20040022740A1 (en) | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| ES2278823T3 (es) | 2002-03-01 | 2007-08-16 | Chiesi Farmaceutici S.P.A. | Composiciones que comprenden tensioactivos pulmonares y una polimixina que tienen propiedades de superficie mejoradas. |
| WO2008025560A1 (en) * | 2006-09-01 | 2008-03-06 | Pari Pharma Gmbh | Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy |
| US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| US8329645B2 (en) | 2008-02-08 | 2012-12-11 | Northern Antibiotics Ltd. | Polymyxin derivatives and uses thereof |
| US9005990B2 (en) | 2009-10-30 | 2015-04-14 | Xellia Pharmaceuticals Aps | Method for purification of colistin and purified colistin components |
| CN102190710A (zh) * | 2010-01-22 | 2011-09-21 | 上海医药工业研究院 | 多黏菌素e2组合物及其制备方法和用途 |
| GB201010500D0 (en) | 2010-06-23 | 2010-08-04 | Univ Cardiff | Therapeutic conjugates |
| WO2012168820A1 (en) | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| CN102531955B (zh) | 2011-09-16 | 2014-02-19 | 浙江众益制药股份有限公司 | 奥沙拉秦钠的制备方法和甲磺化反应的后处理方法 |
| CA2895910C (en) | 2013-01-11 | 2021-12-21 | Xellia Pharmaceuticals Aps | Polymyxins, compositions, methods of making and methods of use |
| TW201522364A (zh) | 2013-06-07 | 2015-06-16 | Xellia Pharmaceuticals Aps | 黏菌素甲磺酸鈉（ｃｍｓ）之定性方法 |
| ES2749053T3 (es) | 2014-07-09 | 2020-03-18 | Xellia Pharmaceuticals Aps | Polimixinas de baja sustitución y sus composiciones |
| CA2962120C (en) | 2014-10-03 | 2023-09-19 | Xellia Pharmaceuticals Aps | Inhalation device |
-
2015
- 2015-10-01 PT PT157751736T patent/PT3200827T/pt unknown
- 2015-10-01 RS RS20201176A patent/RS60874B1/sr unknown
- 2015-10-01 UA UAA201704127A patent/UA119573C2/uk unknown
- 2015-10-01 EP EP15775173.6A patent/EP3200827B1/en active Active
- 2015-10-01 AU AU2015326842A patent/AU2015326842B2/en active Active
- 2015-10-01 CA CA2961700A patent/CA2961700C/en active Active
- 2015-10-01 EP EP20176607.8A patent/EP3718571A1/en not_active Withdrawn
- 2015-10-01 US US15/516,243 patent/US10532080B2/en active Active
- 2015-10-01 DK DK15775173.6T patent/DK3200827T3/da active
- 2015-10-01 ES ES15775173T patent/ES2822943T3/es active Active
- 2015-10-01 HU HUE15775173A patent/HUE052028T2/hu unknown
- 2015-10-01 PL PL15775173T patent/PL3200827T3/pl unknown
- 2015-10-01 CN CN201580053905.8A patent/CN106794221B/zh active Active
- 2015-10-01 SI SI201531386T patent/SI3200827T1/sl unknown
- 2015-10-01 SG SG11201702717XA patent/SG11201702717XA/en unknown
- 2015-10-01 KR KR1020177011539A patent/KR102433278B1/ko active IP Right Grant
- 2015-10-01 JP JP2017517047A patent/JP6633061B2/ja active Active
- 2015-10-01 RU RU2017114136A patent/RU2712276C2/ru active
- 2015-10-01 WO PCT/EP2015/072728 patent/WO2016050928A1/en active Application Filing
- 2015-10-01 BR BR112017006848-6A patent/BR112017006848B1/pt active IP Right Grant
- 2015-10-01 MX MX2017004176A patent/MX2017004176A/es active IP Right Grant
-
2017
- 2017-03-17 PH PH12017500516A patent/PH12017500516A1/en unknown
- 2017-03-23 ZA ZA2017/02047A patent/ZA201702047B/en unknown
- 2017-03-30 IL IL251479A patent/IL251479B/en active IP Right Grant
- 2017-04-28 CO CONC2017/0004303A patent/CO2017004303A2/es unknown
-
2020
- 2020-10-07 HR HRP20201598TT patent/HRP20201598T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201598T1 (hr) | Pripravci | |
| HRP20210529T1 (hr) | Inhibitori za mk2 i njihove uporabe | |
| CY1121928T1 (el) | Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης | |
| BR112018075140A2 (pt) | composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8 | |
| TR201908736T4 (tr) | Trk-inhibe eden bileşiğin asit eklenmiş tuzu. | |
| MX2016016593A (es) | Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos. | |
| MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
| CO2017007137A2 (es) | Composición farmacéutica que comprende plasminógeno y usos de este | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| PH12015502013A1 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| BR112017004798A2 (pt) | composição farmacêutica que contém um derivado de ácido hidroxâmico ou um seu sal | |
| EA201690859A1 (ru) | Предотвращение инфекций, вызываемых staphylococcus aureus, гликопротеиновыми вакцинами, синтезированными в escherichia coli | |
| BR112017000246A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal | |
| BR112018073524A2 (pt) | composto, composição farmacêutica, combinação, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição. | |
| EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
| WO2016038521A8 (en) | Pharmaceutical compositions of liraglutide | |
| HRP20220903T1 (hr) | Seladelpar za liječenje primarnog bilijarnog kolangitisa | |
| BR112018010052A2 (pt) | peptídeos com propriedades antiangiogênicas, antilinfangiogênicas e antiedêmicas e formulações de nanopartícula | |
| PH12016502293A1 (en) | Naphthyridinedione derivatives | |
| EA201691792A1 (ru) | Фармацевтические составы на основе вилдаглиптина | |
| BR112017019364A2 (pt) | dispersões sólidas | |
| MX2017002737A (es) | Farmaceutico que contiene inhibidor de transportador de fosfato dependiente de sodio. | |
| EA201501130A1 (ru) | Офтальмологическая фармацевтическая композиция | |
| BR112016008704A8 (pt) | derivados de indol-urea glucopiranosil-substituídos, composições farmacêuticas, e seus usos |